Adjuvant Treatment of Apatinib in Nasopharyngeal Carcinoma

Clinical trial NCT03612219 · UNKNOWN

Trial details

NCT number: NCT03612219
Sponsor: Wei Jiang
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Nasopharyngeal Carcinoma

Start date: 2018-07-01
Primary completion: 2021-07-28
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.